Integrated Care News by CFHA
MAY 8, 2025
Vaccine hesitancy is the delay in accepting or refusing vaccination despite the availability of vaccination services. It falls on a spectrum of vaccine attitudes and intentions, from those who recognize the importance of vaccines and accept all vaccines on one end of the spectrum to those who refuse all vaccines.
Minnesota Academy of Family Physicians
JUNE 20, 2025
AAFP Denounces Changes to ACIP and Vaccine Recommendations The Minnesota Academy of Family Physicians (MAFP) stands with the American Academy of Family Physicians (AAFP) in denouncing the recent decisions made by Health and Human Services (HHS) Secretary, Robert F. Kennedy, Jr. Call to Action The MAFP urges members to speak out.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Annals of Family Medicine
NOVEMBER 20, 2024
Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter.
Annals of Family Medicine
NOVEMBER 20, 2024
Models were adjusted for key recipient demographics and heatlcare utilization. Comp ared to all other Ontario residents, MA service recipients were more likely to be attached to a primary care provider (odds ratio [95% confidence interval]: 1.92 [1.90-1.93]), 1.58]; flu/COVID-19 vaccination: 1.69 [1.68-1.70]).
Alabama Academy of Family Physicians
FEBRUARY 19, 2025
HB 2 – Vaccine Consent What’s in the Bill: Sponsored by Rep. Under current law, minors aged 14 or older are permitted to consent to vaccines (excluding the Covid Vaccine) for themselves without parental consent. Here’s a brief overview of the key pieces of legislation that AAFP is diligently monitoring.
FDA Law Blog
JUNE 7, 2021
It is noteworthy that this sentence that no clinical benefit has been established was deemed by FDA as unnecessary for Aduhelm to provide additional context beyond that the approval is based on reduction in amyloid beta plaques. be “reasonably likely to predict” ultimate clinical benefit). Yesterday’s approval of Aduhelm helped answer that.
BMJ
MAY 10, 2022
Introductory article to İkİIşik H, Sezerol MA, Taşçı Y, et alCOVID-19 vaccine hesitancy and related factors among primary healthcare workers in a district of Istanbul: a cross-sectional study from TurkeyFamily Medicine and Community Health 2022;10:e001430. 29% (n=86) of the participants were undecided about getting vaccinated.
Expert insights. Personalized for you.
130 
Let's personalize your content